Jake Tapper's Remarks About the Trump and the Leaked Trash Intel Report Are...
NATO Secretary-General Did Not Just Say That to Trump
Trump Once Again Got Under CNN's Skin...and It's Beautiful to Watch
Trump Eviscerates Socialist NYC Mayoral Candidate, Offers Some Hilarious Advice for Democr...
CNN Has Been Having a Horrendous Time of It Since the Iran Bombing...
Florida Workers Win Big With Trump's No Tax on Tips
Stealth, Nukes, and NATO: Britain Re-Arms for a New Era
Tulsi Gabbard: Natanz, Fordow, and Isfahan Are Gone
Adams Rips Mamdani As a 'Snake Oil Salesman'
Watch Out, NYC: Another Squad Member Supports Mamdani for Mayor
Cruz Calls Out Dems While Highlighting How Left's Attacks on Energy Agenda Are...
Maine Democrats Finally Allow State Rep. Laurel Libby to Vote and Speak on...
Will These Reactions to Mamdani's Primary Win Affect NY's '26 Gubernatorial Election?
Texas Lawmaker Proposes Bill to Block Abortionists From Flushing Fetal Remains
As Biden Aide Refuses to Appear for Interview, Chairman Comer Says He'll 'Promptly'...
Tipsheet

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

President Biden on Monday nominated Dr. Monica Bertagnolli, a surgical oncologist and head of the National Cancer Institute, to be the next director of the National Institutes of Health, but critics say the White House left out an important detail about her background in the administration’s announcement.  

Advertisement

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said in a statement.
 
“As Director of the National Cancer Institute, Dr. Bertagnolli has advanced my Cancer Moonshot to end cancer as we know it. She has brought together partners and resources from different sectors to launch groundbreaking efforts in cancer prevention and early detection, a national navigation program for childhood cancers, and additional programs to bring clinical trials to more Americans,” the statement continued. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.” 

As Democratic presidential candidate Robert F. Kennedy Jr. and others pointed out, she’s a “revolving door” nominee. 

“From 2015-2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her. research grants,” he tweeted. 

Kennedy was sure to point out this doesn’t automatically make her “personally corrupt,” but that she will champion Big Pharma’s viewpoints.  

Advertisement

“That is how agencies are captured,” he added, commenting later that he was not surprised the White House left this detail out of the announcement. 


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement